Pregnancy Risk Category B
How supplied
Tablets: 1 g
Suspension: 1 g/10 ml
Action
Unknown. Probably adheres to and protects the ulcer's surface by forming a barrier.
Indications & dosage
Short-term (up to 8 weeks) treatment of duodenal ulcer--
Adults: 1 g P.O. q.i.d. 1 hour before meals and h.s.
Maintenance therapy for duodenal
ulcer--
Adults: 1 g P.O. b.i.d.
Adverse reactions
CNS: dizziness, sleepiness, headache, vertigo.
GI: constipation, nausea, gastric discomfort, diarrhea, bezoar formation, vomiting, flatulence, dry mouth, indigestion.
Musculoskeletal: back pain.
Skin: rash, pruritus.
Interactions
Drug-drug. Antacids: may decrease binding of drug to gastroduodenal mucosa, impairing effectiveness. Don't administer within 30 minutes of each other.
Cimetidine, ciprofloxacin, digoxin, ketoconazole, norfloxacin, phenytoin, quinidine, ranitidine, tetracycline, theophylline: decreased absorption. Separate administration times by at least 2 hours.
Effects on diagnostic tests
None reported.
Contraindications
No known contraindications.
Nursing considerations
Patient teaching
*Liquid contains alcohol. **May contain tartrazine. †Canada ‡Australia §U.K. OTCOver the counter
Reactions may be common, uncommon, life-threatening, or COMMON AND LIFE-THREATENING